Article Versions Notes

Fumarulo I, Pasquini A, La Vecchia G, Pellizzeri B, Sten A, Garramone B, Vaccarella M, Ravenna SE, Lombardo A, Burzotta F, et al. Evaluation of the Effects of the Sodium–Glucose Cotransporter 2 Inhibitors and Sacubitril/Valsartan Combined Therapy in Patients with HFrEF: An Echocardiographic Study. International Journal of Molecular Sciences. 2025; 26(12):5651. https://doi.org/10.3390/ijms26125651

Fumarulo, Isabella, Annalisa Pasquini, Giulia La Vecchia, Bianca Pellizzeri, Andriy Sten, Barbara Garramone, Marcello Vaccarella, Salvatore Emanuele Ravenna, Antonella Lombardo, Francesco Burzotta, and et al. 2025. "Evaluation of the Effects of the Sodium–Glucose Cotransporter 2 Inhibitors and Sacubitril/Valsartan Combined Therapy in Patients with HFrEF: An Echocardiographic Study" International Journal of Molecular Sciences 26, no. 12: 5651. https://doi.org/10.3390/ijms26125651

Fumarulo, I., Pasquini, A., La Vecchia, G., Pellizzeri, B., Sten, A., Garramone, B., Vaccarella, M., Ravenna, S. E., Lombardo, A., Burzotta, F., Pitocco, D., & Aspromonte, N. (2025). Evaluation of the Effects of the Sodium–Glucose Cotransporter 2 Inhibitors and Sacubitril/Valsartan Combined Therapy in Patients with HFrEF: An Echocardiographic Study. International Journal of Molecular Sciences, 26(12), 5651. https://doi.org/10.3390/ijms26125651